Psychotropic medication use among adolescents and young adults with an autism spectrum disorder: Parent views about medication use and health care services

Simple item page
dc.contributor.authorLake, Johanna K.
dc.contributor.authorVogan, Vanessa
dc.contributor.authorSawyer, Amanda
dc.contributor.authorWeiss, Jonathan
dc.contributor.authorLunsky, Yona
dc.date.accessioned2017-06-21T18:02:00Z
dc.date.available2017-06-21T18:02:00Z
dc.date.issued2015-04
dc.description.abstractObjectives: Psychotropic medications are frequently used to treat mental health and behavioral issues in adolescents and adults with an autism spectrum disorder (ASD). Although parents of individuals with ASD frequently take on medication management for their child, there is limited literature on parent perspectives of their child’s medication use or their views about the health care services they receive, particularly in adulthood. The current study examined and compared parents of adolescents and of young adults with ASD on their child’s psychotropic medication use and their views about health care services. Methods: One hundred parents of adolescents and young adults with ASD (ages 12-30 years) completed an online survey about their experience with their child’s health care services and medication use. Results: Parents of young adults were less likely to use non-pharmacological services before using a psychotropic medication compared to parents of adolescents. Parents of young adults were also less likely to believe their prescribing health care provider had adequate expertise in ASD and were less satisfied with how their prescriber monitored their child’s medication use. Conclusion: Findings highlight the need to build capacity among health care providers supporting individuals with ASD as they transition into adulthood. There is also a need for improved medication monitoring and increased awareness of the different mental health challenges individuals with ASD encounter as they age.en_US
dc.description.sponsorshipFunding Sources: The Canadian Institutes of Health Research (funding reference number 102677) and the Centre for Addiction and Mental Health Postdoctoral Fellowship Award.
dc.identifier.citationJournal of Child and Adolescent Psychopharmacology, 24(9), 486-493
dc.identifier.urihttps://doi.org/10.1089/cap.2014.0106en_US
dc.identifier.urihttp://hdl.handle.net/10315/33233
dc.language.isoenen_US
dc.publisherMary Ann Liebert, Inc. publishersen_US
dc.rightsFinal publication is available from Mary Ann Liebert, Inc., publishers http://online.liebertpub.com/doi/10.1089/cap.2014.0106en_US
dc.rights.articlehttps://doi.org/10.1089/cap.2014.0106
dc.subjectautism spectrum disorderen_US
dc.subjectpsychotropic medicationen_US
dc.subjectyoung adultsen_US
dc.subjectadolescentsen_US
dc.subjecthealth care provideren_US
dc.subjectparent experiencesen_US
dc.titlePsychotropic medication use among adolescents and young adults with an autism spectrum disorder: Parent views about medication use and health care services
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Lake, Vogan, Sawyer, Weiss & Lunsky (2015).pdf
Size:
520.01 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.83 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Department of Psychology

All items in the YorkSpace institutional repository are protected by copyright, with all rights reserved except where explicitly noted.